US 9963504
Anti-CXCL13 antibodies and methods of using the same
granted A61KA61K2039/505A61P
Quick answer
US patent 9963504 (Anti-CXCL13 antibodies and methods of using the same) held by VACCINEX, INC. expires Mon May 03 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VACCINEX, INC.
- Grant date
- Tue May 08 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 03 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K2039/505, A61P, A61P1/04, A61P13/08